BioLight Israeli Life Sciences Investments
BioLight Life Sciences Ltd. is a leading company investing in companies and managing projects relating to eye disease and their treatment. BioLight’s portfolio companies engage in advanced medical devices, medication, diagnostics and digital medicine and all exemplify the enormous potential of Israeli innovation in these fields. Development and commercialization of the company’s ophthalmic technologies and products.
The ophthalmic products developed by the companies in the BioLight group are aimed at innovative diagnosis and treatments for the needs of patient groups suffering from eye diseases. The different ophthalmic products are in various commercialization and clinical (or pre-clinical) phases.
BioLight intends, in line with its financial capabilities, to continue supplementing and expanding the array of technologies and products under development, whether through investment in additional companies or through business development and expansion of the activity of the existing companies.
Top Stages
2 past transactions
BELKIN Vision
Series B in 2020
BELKIN Vision is a company focused on developing innovative laser devices to aid healthcare professionals in the treatment of glaucoma. Its products are characterized by being non-invasive, non-contact, instantaneous, painless, and automated, providing effective laser therapy options. The company's mission is to enhance accessibility to first-line drop-less glaucoma care, enabling any ophthalmologist to effectively treat patients. By streamlining the treatment process, BELKIN Vision aims to improve patient outcomes and overall quality of care within the medical community.
IOPtima
Venture Round in 2015
IOPtima develops minimally invasive ophthalmic laser devices. The flagship IOPtimate system uses CO2 laser technology to treat glaucoma by reducing intraocular pressure through controlled restoration of natural fluid drainage, without penetrating the eye. The system supports a glaucoma procedure known as CLASS (CO2 Laser-Assisted Sclerotomy Surgery), aiming for safe, reproducible outcomes with reduced recovery time. The company also offers the iLid CO2 laser kit to assist oculoplastic surgeons with CO2 laser-assisted blepharoplasty. Founded in 2002 and based in Tel Aviv, Israel, IOPtima operates as part of Bio Light Israeli Life Sciences Investments, focusing on innovative laser solutions for ophthalmic surgery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.